Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs

Pharmacogenetics of Warfarin

(2009) Farhad Kamali et al.   Annual Review of Medicine

10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal

(2009) Daniel Kurnik et al.   PHARMACOGENOMICS

Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

(2008) Rafael G. Amado et al.   JOURNAL OF CLINICAL ONCOLOGY

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE

HLA-B*5701 Screening for Hypersensitivity to Abacavir

(2008) Simon Mallal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fit-for-purpose pharmacogenomic biomarkers in drug development: a project team case study with ‘what-ifs’

(2008) Linda C Surh et al.   PHARMACOGENOMICS